Shreehas Tambe: 'Aim to be among top three biosimilar players in world'
'We've got a huge track record and success in bringing several biosimilars to the market.'
Stay updated with breaking news from Biocon Park. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'We've got a huge track record and success in bringing several biosimilars to the market.'
Based on the OI percentage, 83 stocks, including Aarti Industries, Syngene International, IndiaMART InterMESH, Laurus Labs, and IDFC First Bank, saw long build-ups.
Biocon Biologics' integrated, multi-product, monoclonal antibodies Drug Substance manufacturing facility at Biocon Park, Bengaluru, has received a Certificate of GMP Compliance.
Syngene Intl Share Price: Find the latest news on Syngene Intl Stock Price. Get all the information on Syngene Intl with historic price charts for NSE / BSE. Experts & Broker view also get the Syngene Intl Ltd. buy/sell tips detailed news, announcements, Forecasts, Analysts, Valuation, Earning forecasts, Estimates, Recommendations, Analysts Ratings, financial report, company information, annual report, balance sheet, profit & loss account, results and more.
Bengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd. has announced that the company has received an EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its...